JAGTX vs. JAGLX

Last updated Jun 4, 2026

JAGTX (Janus Global Technology and Innovation Fund) and JAGLX (Janus Henderson Global Life Sciences Fund Class T) are both mutual funds - JAGTX is a Technology Equities fund tracking the MSCI All Country World Information Technology Index, while JAGLX is a Health & Biotech Equities fund actively managed by Janus Henderson. JAGTX is passively managed, while JAGLX is actively managed. Over the past 10 years, JAGTX returned 25.82%/yr vs 10.81%/yr for JAGLX. A 0.65 correlation means they provide meaningful diversification when combined. JAGTX charges 0.91%/yr vs 0.92%/yr for JAGLX.

Performance

JAGTX vs. JAGLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Janus Global Technology and Innovation Fund (JAGTX) and Janus Henderson Global Life Sciences Fund Class T (JAGLX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JAGTX achieves a 35.15% return, which is significantly higher than JAGLX's -3.64% return. Over the past 10 years, JAGTX has outperformed JAGLX with an annualized return of 25.82%, while JAGLX has yielded a comparatively lower 10.81% annualized return.

JAGTX

• 1D: 0.96%
• 1M: 18.03%
• YTD: 35.15%
• 6M: 35.29%
• 1Y: 60.17%
• 3Y*: 41.86%
• 5Y*: 21.73%
• 10Y*: 25.82%

JAGLX

• 1D: -2.63%
• 1M: -1.54%
• YTD: -3.64%
• 6M: -2.05%
• 1Y: 24.95%
• 3Y*: 10.94%
• 5Y*: 7.94%
• 10Y*: 10.81%

*Multi-year figures are annualized to reflect compound growth (CAGR)

JAGTX vs. JAGLX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
JAGTX Janus Global Technology and Innovation Fund	35.15%	24.86%	47.04%	55.16%	-37.69%	17.39%	51.00%	45.08%	0.78%	44.62%
JAGLX Janus Henderson Global Life Sciences Fund Class T	-3.64%	24.72%	8.50%	7.41%	-2.79%	6.66%	25.52%	29.12%	4.05%	22.13%

Correlation

The correlation between JAGTX and JAGLX is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.18
Correlation (3Y) Calculated over the trailing 3-year period	0.36
Correlation (5Y) Calculated over the trailing 5-year period	0.51
Correlation (10Y) Calculated over the trailing 10-year period	0.58
Correlation (All Time) Calculated using the full available price history since Jan 4, 1999	0.65

Over the past year, the correlation between JAGTX and JAGLX has dropped to 0.18 - well below their long-term average of 0.65, suggesting their price drivers have been diverging.

Return for Risk

JAGTX vs. JAGLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JAGTX

JAGTX Risk / Return Rank: 79
JAGTX Sharpe Ratio Rank: 90
JAGTX Sortino Ratio Rank: 77
JAGTX Omega Ratio Rank: 75
JAGTX Calmar Ratio Rank: 83
JAGTX Martin Ratio Rank: 69

JAGLX

JAGLX Risk / Return Rank: 38
JAGLX Sharpe Ratio Rank: 35
JAGLX Sortino Ratio Rank: 36
JAGLX Omega Ratio Rank: 33
JAGLX Calmar Ratio Rank: 48
JAGLX Martin Ratio Rank: 38

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JAGTX vs. JAGLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Janus Global Technology and Innovation Fund (JAGTX) and Janus Henderson Global Life Sciences Fund Class T (JAGLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	JAGTX	JAGLX	Difference
Sharpe ratio Return per unit of total volatility	2.99	1.72	+1.27
Sortino ratio Return per unit of downside risk	3.67	2.52	+1.15
Omega ratio Gain probability vs. loss probability	1.49	1.30	+0.19
Calmar ratio Return relative to maximum drawdown	3.88	2.63	+1.25
Martin ratio Return relative to average drawdown	13.27	8.39	+4.89
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

JAGTX vs. JAGLX - Sharpe Ratio Comparison

The current JAGTX Sharpe Ratio is 2.99, which is higher than the JAGLX Sharpe Ratio of 1.72. The chart below compares the historical Sharpe Ratios of JAGTX and JAGLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	JAGTX	JAGLX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.99	1.72	+1.27
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.81	0.50	+0.31
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	1.05	0.62	+0.42
Sharpe Ratio (All Time) Calculated using the full available price history	0.51	0.58	-0.06

Drawdowns

JAGTX vs. JAGLX - Drawdown Comparison

The maximum JAGTX drawdown since its inception was -84.57%, which is greater than JAGLX's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for JAGTX and JAGLX.

Drawdown Indicators

	JAGTX	JAGLX	Difference
Max Drawdown Largest peak-to-trough decline	-84.57%	-58.96%	-25.61%
Max Drawdown (1Y) Largest decline over 1 year	-15.95%	-9.71%	-6.24%
Max Drawdown (3Y) Largest decline over 3 years	-23.94%	-17.41%	-6.53%
Max Drawdown (5Y) Largest decline over 5 years	-46.52%	-22.25%	-24.27%
Max Drawdown (10Y) Largest decline over 10 years	-46.52%	-27.38%	-19.14%
Current Drawdown Current decline from peak	0.00%	-6.54%	+6.54%
Average Drawdown Average peak-to-trough decline	-39.83%	-17.43%	-22.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.65%	3.03%	+1.62%

Volatility

JAGTX vs. JAGLX - Volatility Comparison

Janus Global Technology and Innovation Fund (JAGTX) has a higher volatility of 6.73% compared to Janus Henderson Global Life Sciences Fund Class T (JAGLX) at 4.69%. This indicates that JAGTX's price experiences larger fluctuations and is considered to be riskier than JAGLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JAGTX	JAGLX	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.73%	4.69%	+2.04%
Volatility (6M) Calculated over the trailing 6-month period	17.01%	10.95%	+6.06%
Volatility (1Y) Calculated over the trailing 1-year period	20.67%	14.85%	+5.82%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.82%	15.92%	+10.90%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.78%	17.41%	+7.37%

JAGTX vs. JAGLX - Expense Ratio Comparison

JAGTX has a 0.91% expense ratio, which is lower than JAGLX's 0.92% expense ratio.

Dividends

JAGTX vs. JAGLX - Dividend Comparison

JAGTX's dividend yield for the trailing twelve months is around 10.13%, more than JAGLX's 4.70% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JAGLX Janus Henderson Global Life Sciences Fund Class T	4.70%	4.53%	10.98%	4.22%	0.14%	9.78%	7.75%	6.17%	13.38%	0.89%	1.13%	9.09%
JAGTX Janus Global Technology and Innovation Fund	10.13%	13.69%	23.66%	0.78%	0.00%	16.05%	9.00%	8.62%	6.56%	7.50%	4.85%	8.12%

Frequently Asked Questions

Can I hold both JAGTX and JAGLX in my portfolio?

JAGTX and JAGLX have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JAGTX or JAGLX?

JAGTX has higher volatility (6.73%) compared to JAGLX (4.69%). In terms of maximum drawdown, JAGTX dropped -84.57% vs JAGLX's -58.96%.

Which has better risk-adjusted returns?

JAGTX currently has the higher Sharpe Ratio (2.99 vs 1.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.